Back to search
FDAFDA · Food and drugs·Recall number F-0328-2024

Similac Probiotic Tri-Blend - 0.017oz (0.50g) packaged in foil packets. 50 foil packets per carton - 3 cartons per case.

Published November 15, 2023 · Recall initiated: October 31, 2023

Summary

FDA records food Class II recall F-0328-2024, published November 15, 2023 and initiated October 31, 2023. Recalling firm: Abbott Laboratories; Status: Terminated; Reported quantity: 226,650 packets (4,533 cartons); Lot: Lot No. 45002IP Product No. 67397 Best By 09/01/24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed towards preterm infants without approval as a new drug or licensed biologic, as well as unsafe food additive

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Abbott Laboratories
Distributor
Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Florida, Georgia, Iowa, Idaho, Illinois, Indiana, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Mississippi, Montana, North Carolina, North Dakota, Nebraska, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin, West Virginia
Lot
Lot No. 45002IP Product No. 67397 Best By 09/01/24
Risk classification
Class II
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was Similac Probiotic Tri-Blend - 0.017oz (0.50g) packaged in foil packets. 50 foil packets per carton - 3 cartons per case. recalled?

Yes. FDA published recall F-0328-2024 on November 15, 2023. Reported hazard: Marketed towards preterm infants without approval as a new drug or licensed biologic, as well as unsafe food additive

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail